ISBN: 978-1-4731-3093-7 9.5.2 Transition between heart failure care settings 419 9.5.3 Information and support needs regarding diagnosis and prognosis 420 10 Advanced heart failure and palliative care 421 10.1 Diuretics in advanced heart failure 421 10.1.2 Review question: Which route of administration of diuretics (intravenous (IV), subcutaneous or oral) is most clinically and cost effective in people with advanced heart failure who are in the community, including patients receiving palliative care? 421 10.1.6 Recommendations and link to evidence 422 10.2 Domiciliary oxygen therapy in people with advanced heart failure 424 10.2.2 Review question: What is the effectiveness of domiciliary oxygen therapy in people with advanced heart failure 424 10.2.6 Recommendations and link to evidence 428 10.3 Discussing Implantable Cardioverter Defibrillatior (ICD) deactivation 430 10.3.2 Review question: What criteria should determine when to discuss defibrillator deactivation? 430 10.3.6 Recommendations and link to evidence 446 10.4 Identifying patients with an increased risk of mortality 450 10.4.2 Review question: In adults with heart failure, which validated risk tools best identify patients with heart failure who are at increased risk of mortality in the short term (up to 1 year)? 450 10.4.4 Discrimination and calibration 466 10.4.7 Recommendations and link to evidence 472 Chronic Heart Failure Contents NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 11 Reference list 478 12 Acronyms and abbreviations 507 13.1 Guideline-specific terms 512 13.2 General terms 513 Chronic Heart Failure Acknowledgements NICE 2018. All rights reserved. Subject to Notice of rights. 